These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 19356514)
1. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography. Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514 [TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Michaels AD; Klein A; Madden JA; Chatterjee K Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984 [TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. Michaels AD; Chatterjee K; De Marco T J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633 [TBL] [Abstract][Full Text] [Related]
4. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356 [TBL] [Abstract][Full Text] [Related]
5. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005 [TBL] [Abstract][Full Text] [Related]
6. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695 [TBL] [Abstract][Full Text] [Related]
7. Nesiritide: a review of its use in acute decompensated heart failure. Keating GM; Goa KL Drugs; 2003; 63(1):47-70. PubMed ID: 12487622 [TBL] [Abstract][Full Text] [Related]
8. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients. Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311 [TBL] [Abstract][Full Text] [Related]
9. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006 [TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of intravenous nesiritide on left ventricular diastolic function in heart failure patients. Efstratiadis S; Michaels AD J Card Fail; 2009 Oct; 15(8):673-80. PubMed ID: 19786256 [TBL] [Abstract][Full Text] [Related]
11. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers. Abraham WT; Cheng ML; Smoluk G; Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969 [TBL] [Abstract][Full Text] [Related]
12. Acute effects of intravenous nesiritide on cardiac contractility in heart failure. Shah SJ; Michaels AD J Card Fail; 2010 Sep; 16(9):720-7. PubMed ID: 20797595 [TBL] [Abstract][Full Text] [Related]
13. Nesiritide for the treatment of decompensated heart failure. Colucci WS J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555 [TBL] [Abstract][Full Text] [Related]
14. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension. Khush KK; De Marco T; Vakharia KT; Harmon C; Fineman JR; Chatterjee K; Michaels AD J Card Fail; 2006 Sep; 12(7):507-13. PubMed ID: 16952783 [TBL] [Abstract][Full Text] [Related]
15. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure. Elkayam U; Cohen G; Gogia H; Mehra A; Johnson JV; Chandraratna PA J Am Coll Cardiol; 1996 Jul; 28(1):176-82. PubMed ID: 8752811 [TBL] [Abstract][Full Text] [Related]
16. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724 [TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089 [TBL] [Abstract][Full Text] [Related]
18. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755 [TBL] [Abstract][Full Text] [Related]
19. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related]